Estimating the association between metabolic risk factors and marijuana use in U.S. adults using data from the continuous National Health and Nutrition Examination Survey

Annals of Epidemiology
Christin Ann Thompson, Joel W Hay

Abstract

More research is needed on the health effects of marijuana use. Results of previous studies indicate that marijuana could alleviate certain factors of metabolic syndrome, such as obesity. Data on 6281 persons from National Health and Nutrition Examination Survey from 2005 to 2012 were used to estimate the effect of marijuana use on cardiometabolic risk factors. The reliability of ordinary least squares (OLS) regression models was tested by replacing marijuana use as the risk factor of interest with alcohol and carbohydrate consumption. Instrumental variable methods were used to account for the potential endogeneity of marijuana use. OLS models show lower fasting insulin, insulin resistance, body mass index, and waist circumference in users compared with nonusers. However, when alcohol and carbohydrate intake substitute for marijuana use in OLS models, similar metabolic benefits are estimated. The Durbin-Wu-Hausman tests provide evidence of endogeneity of marijuana use in OLS models, but instrumental variables models do not yield significant estimates for marijuana use. These findings challenge the robustness of OLS estimates of a positive relationship between marijuana use and fasting insulin, insulin resistance, body mass inde...Continue Reading

References

Sep 1, 1986·Pharmacology, Biochemistry, and Behavior·R W FoltinM W Fischman
Nov 27, 1999·Forschende Komplementärmedizin·R G Pertwee
Nov 27, 1999·Forschende Komplementärmedizin·R W Gorter
Aug 6, 2000·JAMA : the Journal of the American Medical Association·N A RigottiH Wechsler
Nov 18, 2000·Proceedings of the Society for Experimental Biology and Medicine·W C Willett
Jan 16, 2002·JAMA : the Journal of the American Medical Association·Earl S FordWilliam H Dietz
May 23, 2003·The New England Journal of Medicine·Gary D FosterSamuel Klein
Sep 27, 2005·Lancet·K George M M AlbertiUNKNOWN IDF Epidemiology Task Force Consensus Group
Sep 28, 2005·Journal of Addictive Diseases·Matthew WarrenMark Gold
Aug 9, 2006·The American Journal of Cardiology·Nicolas RodondiUNKNOWN Coronary Artery Risk Development in Young Adults (CARDIA) Study
Feb 23, 2010·American Journal of Preventive Medicine·Tilda FarhatBruce G Simons-Morton
Oct 13, 2010·The American Journal of Drug and Alcohol Abuse·Mohammad R HayatbakhshJake M Najman
May 6, 2011·BMC Medicine·Eva KassiGeorge Chrousos
Aug 27, 2011·American Journal of Epidemiology·Yann Le Strat, Bernard Le Foll
Nov 2, 2011·American Journal of Health Behavior·Kushal PatelWilliam J Blot
Mar 27, 2013·Diabetes Care·Ranganath MuniyappaMonica C Skarulis
May 21, 2013·The American Journal of Medicine·Elizabeth A PennerMurray A Mittleman

❮ Previous
Next ❯

Citations

Jan 7, 2017·PloS One·Lexie Zhiyan JinBerit L Heitmann
Jan 11, 2018·Transplantation·Prashant KotwaniBilal Hameed
Dec 28, 2018·Psychosomatic Medicine·Madeline H MeierKaren A Matthews
Jan 24, 2019·Cannabis and Cannabinoid Research·Thomas M ClarkRebecca L Kmiec
Feb 14, 2021·Addiction Biology·Sebastian-Edgar BaumeisterChrista Meisinger
Aug 31, 2021·Reviews in Endocrine & Metabolic Disorders·Farah MeahMary Ann Emanuele

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.